14/05/2026
🌱THIS IS A HUGE STEP FORWARD🌱
🌱On Tuesday at the European Congress of Endocrinology in Prague, endocrinologist Helena Teede from announced that it will now be known as polyendocrine metabolic ovarian syndrome (PMOS).
🌱The old name focused mainly on “cysts” (which are actually follicles), while many women experience symptoms affecting their entire body - including hormones, metabolism, insulin resistance, energy, weight, skin, mood, and fertility.
🌱The new name aims to better reflect the true nature of the condition as a whole-body hormonal and metabolic disorder.
The goals behind the change:
• Improve diagnosis rates
• Reduce stigma and confusion
• Increase awareness and research
• Better represent women’s real experiences
This change followed a 14-year international effort involving 56 health organisations and more than 14,000 patients and healthcare professionals.
PMOS affects around 1 in 8 women worldwide and can impact metabolic health, fertility, and long-term risk of conditions like Type 2 diabetes.
What are your thoughts on the new name? ⬇️